N

NeoPharm Co Ltd
KOSDAQ:092730

Watchlist Manager
NeoPharm Co Ltd
KOSDAQ:092730
Watchlist
Price: 19 110 KRW 9.58%
Market Cap: 306.3B KRW

Operating Margin

21.7%
Current
Declining
by 2%
vs 3-y average of 23.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
21.7%
=
Operating Income
₩28.2B
/
Revenue
₩129.8B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
21.7%
=
Operating Income
₩28.2B
/
Revenue
₩129.8B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
NeoPharm Co Ltd
KOSDAQ:092730
298.9B KRW
Loading...
FR
L'Oreal SA
PAR:OR
206.7B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
118.1B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.6T INR
Loading...
UK
HALEON PLC
LSE:HLN
33.9B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
43B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.8B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
931.8B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Higher than 92% of companies in Korea
Percentile
92nd
Based on 2 615 companies
92nd percentile
21.7%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

NeoPharm Co Ltd
Glance View

Market Cap
306.3B KRW
Industry
Consumer products

NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2007-01-30. The firm produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. The company also engages in the original equipment manufacturing (OEM) of skin drugs.

NeoPharm Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
21.7%
=
Operating Income
₩28.2B
/
Revenue
₩129.8B
What is NeoPharm Co Ltd's current Operating Margin?

The current Operating Margin for NeoPharm Co Ltd is 21.7%, which is below its 3-year median of 23.7%.

How has Operating Margin changed over time?

Over the last 3 years, NeoPharm Co Ltd’s Operating Margin has decreased from 24.9% to 21.7%. During this period, it reached a low of 20.7% on Dec 31, 2024 and a high of 26.4% on Sep 30, 2023.

Back to Top